New technologies, such as the cloud and artificial intelligence, have transformed pharmaceutical supply chains from materials supplier to manufacturer, wholesaler to pharmacy and on to patients
Damaged by past digital disasters, the NHS looks to innovative technology to heal its wounds, but is there sufficient financial commitment and political leadership to see through a successful transition?
Manufactured when an original biologic drug’s patent expires, biosimilars can increase access to treatment options and improve patient outcomes
Breakthroughs in diabetes care are eliminating much of the pain and anguish of living with the disease, and reducing the risk of life-threatening complications
Benefits of prescribing by brand, enabling the costly development of life-changing drugs, may be outweighed by higher costs, compared with cheaper generic bio-equivalents
Harnessing the power of the body’s immune system to fight cancer is one of the most exciting breakthroughs in treatment, but there remains much to be done and understood
Of the 281,000 registered clinical studies recorded worldwide by Statista this year, thousands are of cardiovascular disease which accounts for 31 per cent of all global deaths
Co-ordinated healthcare, recognising the links between cardiovascular disease and other conditions, would prevent illness and provide better outcomes for patients